marketcaparena
Search

    ELOX

    Eloxx Pharmaceuticals, Inc.

    Company overview

    Market capitalization
    $60.55M
    Employees
    —
    Latest publication
    2026-09-29

    Financial statements

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Assets63,388,000USD
    Cash And Equivalents61,960,000USD
    Total Current Assets63,388,000USD
    Other Current Assets1,422,000USD
    Total Liabilities16,968,000USD
    Total Current Liabilities16,968,000USD
    Other Current Liabilities2,047,000USD
    Total Stockholder Equity46,420,000USD
    Total Equity Including Noncontrolling Interest46,420,000USD
    Short Long Term Debt0USD
    Accounts Payable3,028,000USD
    Common Stock40,000USD
    Retained Earnings-308,836,000USD
    SourceDisclosureDeterministicFinal

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation141,000USD
    Other Non Cash Items56,000USD
    Change To Liabilities-1,226,000USD
    Change In Working Capital-1,410,000USD
    Operating Cash Flow-10,242,000USD
    Net Debt Issuance0USD
    Unclassified Financing Cash Flow67,417,000USD
    Financing Cash Flow67,417,000USD
    Change In Cash57,175,000USD
    End Cash Flow61,966,000USD
    SourceDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.